GoodRx Holdings, Inc. (GDRX) Deferred Income Tax Expense (Benefit)

GoodRx Holdings, Inc. Deferred Income Tax Expense (Benefit)

GoodRx Holdings, Inc. (GDRX) reported Deferred Income Tax Expense (Benefit) of $9.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-05

• GoodRx Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $5.71M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $4.07M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $11.98M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $8.09M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for fiscal 2025 was $20.07M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$11.91M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$65.56M.
• GoodRx Holdings, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$497.00K, a 103.87% decline from fiscal 2021.